Biogen ALS Drug Granted FDA Priority Review, Triggering Aduhelm Déjà Vu

 
• By Jessica Merrill
  
train track
Biogen's tofersen NDA follows a familiar track • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category